M Barinaga. Show Affiliations »
Abstract
Mesh： See more » Angiogenesis Inhibitors/administration & dosageAngiogenesis Inhibitors/therapeutic useAngiogenesis Inhibitors/toxicityAnimalsAntineoplastic Combined Chemotherapy Protocols/administration & dosageAntineoplastic Combined Chemotherapy Protocols/therapeutic useAntineoplastic Combined Chemotherapy Protocols/toxicityClinical Trials as TopicCyclohexanesHumansMiceNeoplasms/drug therapyNeoplasms/pathologyNeoplasms, Experimental/drug therapyNeoplasms, Experimental/pathologyNeovascularization, Pathologic/drug therapyNeovascularization, Pathologic/pathologyO-(Chloroacetylcarbamoyl)fumagillolSesquiterpenes/administration & dosageSesquiterpenes/therapeutic use
Substances： See more » Angiogenesis InhibitorsCyclohexanesSesquiterpenesO-(Chloroacetylcarbamoyl)fumagillol
Year: 2000 PMID： 10777399 DOI： 10.1126/science.288.5464.245a
Source DB: PubMed Journal: Science ISSN： 0036-8075 Impact factor: 47.728